Microba Life SciencesASX:MAP +19.44% Days Inventory is 92.01 as of Dec. 2025, which is 21% above its 10-year median of 76.02. The stock has 6 warning signs investors should review. Among 176 Medical Diagnostics & Research companies, Microba Life Sciences ranks worse than 64.77% on this metric.
The historical rank and industry rank for Microba Life Sciences's Days Inventory or its related term are showing as below:
ASX:MAP'
s Days Inventory Range Over the Past 10 Years
Min: 56.56 Med: 76.02 Max: 94.11
Current: 94.11
During the past 4 years, Microba Life Sciences's highest Days Inventory was 94.11. The lowest was 56.56. And the median was 76.02.
ASX:MAP's Days Inventory is ranked worse than 64.77% of 176
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88
vs ASX:MAP: 94.11
Microba Life Sciences's Days Inventory
declined
from Dec. 2024 (93.97) to Dec. 2025 (92.01).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Microba Life Sciences's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.98.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Microba Life Sciences's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.27.
Microba Life Sciences (ASX:MAP) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Microba Life Sciences's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Microba Life Sciences's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Microba Life Sciences Days Inventory Related Terms
Microba Life Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Microba Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:MAP vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Microba Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microba Life Sciences Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Microba Life Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences (ASX:MAP) has a Days Inventory of 92.01 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Microba Life Sciences and its competitors. This is 21% above median its historical median of 76.02. Over the past decade, Microba Life Sciences' Days Inventory has ranged from 56.56 to 94.11. According to the industry distribution chart, Microba Life Sciences ranks #114 out of 176 companies in the Medical Diagnostics & Research industry, placing it in the top 64.8%.
Is Microba Life Sciences' Days Inventory too high?
Microba Life Sciences' current Days Inventory of 92.01 is 21% above median its 10-year median of 76.02. Over the past 10 years, this metric has ranged from a low of 56.56 to a high of 94.11. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Microba Life Sciences' value of 92.01 is 33.6% above this industry median. Based on the distribution chart, Microba Life Sciences ranks #114 out of 176 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does Microba Life Sciences' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Microba Life Sciences ranks #114 out of 176 companies for Days Inventory. This places Microba Life Sciences in the lower half of its industry. The industry median Days Inventory is 68.88. Microba Life Sciences' value of 92.01 is 33.6% above this benchmark. Historically, Microba Life Sciences' own Days Inventory has ranged from 56.56 to 94.11 over the past decade. While the company's 10-year median is 76.02 vs. the industry median of 68.88, Microba Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Microba Life Sciences's current Days Inventory of 92.01 is 33.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Microba Life Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microba Life Sciences's current Days Inventory is 92.01, which is 21% above median its own 10-year median of 76.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.25, compared to a current price of A$0.04 — trading 82.8% below its estimated fair value. The current Days Inventory is 92.01, which is 21% above median its 10-year median of 76.02 and 33.6% above the Medical Diagnostics & Research industry median of 68.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current Days Inventory is 92.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MAP has been successfully added to your 